Mumbai, November 11, 2018: Cipla Limited (BSE: 500087, NSE: CIPLA) today announced its unaudited consolidated financial results for quarter ended…
Advocates timely intervention that can help one lead a better quality of life Integrated Communication Campaign planned Mumbai, September 04,…
Mumbai, August 10, 2018: Cipla Limited (“Cipla”) announced that it has received final approval on August 3, 2018, for its…
New Delhi, June 20, 2018: Drug major Cipla on Tuesday said it has received approval from the US health regulator to market Efavirenz…
New Delhi, June 06, 2018: Cipla has initiated ‘INNOVENTIA’ that is envisioned to be the world’s biggest innovation challenge to…
Mumbai, April 21,2018: Pharma Major, Cipla Ltd ssaid that US Food and Drug Administration (USFDA) has conducted a routine current Good…
Sundyota Numand is will also co-market this product with Cipla Ahmedabad, April 14, 2018: Sundyota Numandis Group of companies, a global health…
New Delhi, March 29, 2018: Management teams were generally optimistic on the outlook for domestic Indian markets, with sales growth…
New Delhi, February 24, 2018: Indian pharmaceutical organizations have gotten 29 for every penny of US FDA cautioning letters in…